MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 534941 | Name: Tribendimidine
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tribendimidine (TBD) is a broad-spectrum anthelmintic drug that is also significantly effective in treating clonorchiasis. It is a derivative of amidantel. Tribendimidine was as effective as praziquantel against O. felineus liver flukes.

Chemical Structure

Tribendimidine
Tribendimidine
CAS#115103-15-6

Theoretical Analysis

MedKoo Cat#: 534941

Name: Tribendimidine

CAS#: 115103-15-6

Chemical Formula: C28H32N6

Exact Mass: 452.2688

Molecular Weight: 452.61

Elemental Analysis: C, 74.30; H, 7.13; N, 18.57

Price and Availability

Size Price Availability Quantity
25mg USD 450.00 2 Weeks
50mg USD 750.00 2 Weeks
100mg USD 1,250.00 2 Weeks
200mg USD 2,250.00 2 Weeks
500mg USD 3,650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Tribendimidine
IUPAC/Chemical Name
Ethanimidamide, N',N'''-(1,4-phenylenebis(methylidynenitrilo-4,1-phenylene))bis(N,N-dimethyl-Tribendimidine
InChi Key
XOIOGKHKNQYULW-HTNNXBMUSA-N
InChi Code
InChI=1S/C28H32N6/c1-21(33(3)4)31-27-15-11-25(12-16-27)29-19-23-7-9-24(10-8-23)20-30-26-13-17-28(18-14-26)32-22(2)34(5)6/h7-20H,1-6H3/b29-19+,30-20+,31-21+,32-22+
SMILES Code
C/C(N(C)C)=N\C1=CC=C(/N=C/C2=CC=C(/C=N/C3=CC=C(/N=C(N(C)C)\C)C=C3)C=C2)C=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 452.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Malinverno M, Callegari E, Pirona L, Pellerani I, Belmonte B, Tripodo C, Angelico P, Biondi S. Procto-Glyvenol© accelerates the natural healing process of wounds: a pre-clinical study. Eur Rev Med Pharmacol Sci. 2023 Sep;27(17):8269-8279. doi: 10.26355/eurrev_202309_33587. PMID: 37750654. 2: Sidorova AV, Yunusov BT, Groshilin VS, Arkharov AV, Aliev VA. Sovremennye trendy v kombinirovannom lechenii gemorroya: primenenie mestnoi formy tribenozid + lidokain i sistemnogo venotoniziruyushchego preparata ginkgo biloba + trokserutin + geptaminol [Modern trends in combined treatment of hemorrhoids: topical form Tribenoside + Lidocaine and phlebotonic Ginkgo biloba + Troxerutin + Heptaminol]. Khirurgiia (Mosk). 2022;(12. Vyp. 2):90-97. Russian. doi: 10.17116/hirurgia202212290. PMID: 36562679. 3: Malinauskienė L, Černiauskas K, Griguola L, Chomičiene A. Contact allergy to tribenoside: A rare allergen. Contact Dermatitis. 2021 Dec;85(6):718-719. doi: 10.1111/cod.13952. Epub 2021 Aug 11. PMID: 34322884. 4: Kestřánek J. Hemorrhoid management in women: the role of tribenoside + lidocaine. Drugs Context. 2019 Sep 13;8:212602. doi: 10.7573/dic.212602. PMID: 31555338; PMCID: PMC6752749. 5: Lin P, Zhong XZ, Wang XD, Li JJ, Zhao RQ, He Y, Jiang YQ, Huang XW, Chen G, He Y, Yang H. Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma. Oncol Rep. 2018 Dec;40(6):3189-3198. doi: 10.3892/or.2018.6710. Epub 2018 Sep 18. PMID: 30272356; PMCID: PMC6196639. 6: Lorenc Z, Gökçe Ö. Tribenoside and lidocaine in the local treatment of hemorrhoids: an overview of clinical evidence. Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2742-51. PMID: 27383331. 7: Walsh S, Donnan J, Morrissey A, Sikora L, Bowen S, Collins K, MacDonald D. A systematic review of the risks factors associated with the onset and natural progression of hydrocephalus. Neurotoxicology. 2017 Jul;61:33-45. doi: 10.1016/j.neuro.2016.03.012. Epub 2016 Mar 18. PMID: 27000516. 8: Plenis A, Konieczna L, Miękus N, Bączek T. Development of the HPLC Method for Simultaneous Determination of Lidocaine Hydrochloride and Tribenoside Along with Their Impurities Supported by the QSRR Approach. Chromatographia. 2013 Mar;76(5-6):255-265. doi: 10.1007/s10337-012-2339-9. Epub 2012 Nov 1. PMID: 23482886; PMCID: PMC3585984. 9: Kubicsek T, Kazy Z, Czeizel AE. Teratogenic potential of tribenoside, a drug for the treatment of haemorrhoids and varicose veins--a population-based case-- control study. Reprod Toxicol. 2011 May;31(4):464-9. doi: 10.1016/j.reprotox.2010.12.001. Epub 2010 Dec 21. PMID: 21182931. 10: Kikkawa Y, Takaki S, Matsuda Y, Okabe K, Taniguchi M, Oomachi K, Samejima T, Katagiri F, Hozumi K, Nomizu M. The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells. Biol Pharm Bull. 2010;33(2):307-10. doi: 10.1248/bpb.33.307. PMID: 20118558. 11: Inoue A, Tamagawa-Mineoka R, Katoh N, Kishimoto S. Allergic contact dermatitis caused by tribenoside. Contact Dermatitis. 2009 Jun;60(6):349-50. doi: 10.1111/j.1600-0536.2009.01544.x. PMID: 19489977. 12: Aliev SA, Ibishov KG, Aliev ES. [Certain aspects of pathogenesis of hemorheological and trophic disturbances and their pharmacological correction in patients with chronic venous insufficiency]. Vestn Khir Im I I Grek. 2008;167(2):39-43. Russian. PMID: 18522184. 13: Hashizume H, Takigawa M. Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells. Acta Derm Venereol. 2005;85(1):47-50. doi: 10.1080/00015550410024094. PMID: 15848991. 14: Endo H, Kawada A, Yudate T, Aragane Y, Yamada H, Tezuka T. Drug eruption due to tribenoside. Contact Dermatitis. 1999 Oct;41(4):223. doi: 10.1111/j.1600-0536.1999.tb06137.x. PMID: 10515105. 15: Chayen J, Bitensky L, Chambers MG. Modulation of murine osteoarthritis. Cell Biochem Funct. 1996 Mar;14(1):57-61. doi: 10.1002/cbf.643. PMID: 8907255. 16: Poprzen V, Popović R. Spektrodenzitometrijsko odredivanje lidokain-hlorida u nekim antihemoroidalijama [Spectrodensitometric determination of lidocaine- chloride in antihemorrhoidal agents]. Vojnosanit Pregl. 1989 May- Jun;46(3):191-4. Serbian. PMID: 2815634. 17: Wilhelmi G, Tanner K. Einfluss von Riboflavin (Vitamin B2) auf die spontane Gonarthrose der Maus [Effect of riboflavin (vitamin B2) on spontaneous gonarthrosis in the mouse]. Z Rheumatol. 1988 May-Jun;47(3):166-72. German. PMID: 3213264. 18: Modin AIu. Otsenka sostoianiia gemodinamiki cheloveka posle odnokratnogo priema glivenola [Evaluation of human hemodynamic function after a single dose of glyvenol]. Farmakol Toksikol. 1988 Jan-Feb;51(1):71-2. Russian. PMID: 3360113. 19: Zil'berman IuV. Korrektsiia élektroforezom glivenola narusheniia mikrotsirkuliatsii pri parodontite [Glyvenol electrophoresis in the correction of microcirculation disorders in parodontitis]. Vopr Kurortol Fizioter Lech Fiz Kult. 1983 Sep-Oct;(5):54-5. Russian. PMID: 6689233. 20: Colombo C, Butler M, Hickman L, Selwyn M, Chart J, Steinetz B. A new model of osteoarthritis in rabbits. II. Evaluation of anti-osteoarthritic effects of selected antirheumatic drugs administered systemically. Arthritis Rheum. 1983 Sep;26(9):1132-9. doi: 10.1002/art.1780260911. PMID: 6688529.